00:00
02:25
Drs. Nate Pennell, Mary Pinder, and Jack West discuss the START trial of L-BLP-25 (tecemotide) immunotherapy in locally advanced NSCLC.
Drs. Nate Pennell, Mary Pinder, and Jack West discuss the START trial of L-BLP-25 (tecemotide) immunotherapy in locally advanced NSCLC. read more read less

10 years ago #2013, #advanced, #cancer, #center, #cleveland, #clinic, #grace, #howard, #iii, #institute, #jack, #locally, #mary, #moffitt, #nate, #nathan, #pinder, #stage, #swedish, #west